
浏览全部资源
扫码关注微信
复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系,复旦大学病理研究所,上海 200032
[ "王 乾(ORCID: 0000-0001-6998-9740),硕士。" ]
柏乾明(ORCID: 0000-0003-0657-9845),博士,副主任医师。
收稿:2022-05-12,
修回:2022-08-09,
纸质出版:2022-11-30
移动端阅览
王乾, 张静, 郁成礼, 等. 全自动IdyllaTM系统在中国结直肠癌微卫星不稳定性检测中的可行性研究[J]. 中国癌症杂志, 2022,32(11):1084-1090.
Qian WANG, Jing ZHANG, Chengli YU, et al. Validation of the fully automated IdyllaTM system for microsatellite instability detection in Chinese colorectal cancers[J]. China Oncology, 2022, 32(11): 1084-1090.
王乾, 张静, 郁成礼, 等. 全自动IdyllaTM系统在中国结直肠癌微卫星不稳定性检测中的可行性研究[J]. 中国癌症杂志, 2022,32(11):1084-1090. DOI: 10.19401/j.cnki.1007-3639.2022.11.006.
Qian WANG, Jing ZHANG, Chengli YU, et al. Validation of the fully automated IdyllaTM system for microsatellite instability detection in Chinese colorectal cancers[J]. China Oncology, 2022, 32(11): 1084-1090. DOI: 10.19401/j.cnki.1007-3639.2022.11.006.
背景与目的:
微卫星不稳定性(microsatellite instability,MSI)与错配修复(mismatch repair,MMR)基因缺陷,作为结直肠癌(colorectal cancer,CRC)等泛肿瘤免疫治疗的重要生物标志物之一,其检测近年来备受关注。目前临床上常用的多重荧光聚合酶链反应(polymerase chain reaction,PCR)检测MSI的传统方法(如Promega等),通常需要非肿瘤组织对照及较长的检测周期。Idylla
TM
系统作为一种全自动定量PCR装置,检测MSI无需非肿瘤组织对照,且运行时间仅为2.5 h,具有较好的临床应用前景。但在国内临床应用前,应在中国CRC患者中验证该方法的可靠性。
方法:
收集2017年3月—2019年3月复旦大学附属肿瘤医院的87例CRC患者用40%甲醛溶液固定石蜡包埋(formalin-fixed paraffin-embedded,FFPE)的组织样本,分别采用免疫组织化学(immunochemistry,IHC)、传统PCR(Promega)和Idylla
TM
3种方法进行MMR/MSI检测并比较分析,评估Idylla
TM
系统临床检测的灵敏度和特异度以及在不同肿瘤含量样本中的可重复性。
结果:
87例CRC患者中,IHC和Promega的检测结果完全一致,其中56例被判定为MMR缺陷(deficient MMR,dMMR)/高度MSI(MSI-high,MSI-H),31例为MMR完整(proficient MMR,pMMR)/微卫星稳定(micro
satellite stable,MSS)。然而,其中4例dMMR/MSI-H患者被Idylla
TM
MSI系统诊断为MSS,1例pMMR/MSS患者被诊断为MSI-H。若以IHC/Promega为参考标准,Idylla
TM
MSI系统的诊断灵敏度为92.9%(52/56),特异度为96.8%(30/31),总体一致率达94.3%(82/87)。随后,应用Idylla
TM
系统对上述不一致的5例患者进行重复检测,其中4例肿瘤含量≥20%的病例检测结果与IHC/Promega MSI检测一致,但1例肿瘤含量仅为5%的病例仍与IHC/Promega不一致,被误诊为MSS。最后,针对该病例,通过激光捕获显微切割技术对肿瘤细胞进行富集后,应用Idylla
TM
MSI系统再次检测,结果显示为MSI-H。此外,选取5例具有不同肿瘤含量(20% ~ 60%)的病例,分别进行3次重复性验证,结果显示,Idylla
TM
系统具有高度可重复性。
结论:
对于肿瘤含量≥20%的CRC患者,Idylla
TM
系统可以为临床MSI检测提供一种快速、可靠、全自动的解决方案,并具有较高的灵敏度、特异度和可重复性。
Background and purpose:
Microsatellite instability (MSI) and mismatch repair (MMR) defects have attracted much attention recently as one of the important biomarkers for pan-tumor immunotherapy such as colorectal cancer (CRC). Conventional methods for MSI detection with polymerase chain reaction (PCR) often require non-tumor controls as well as a long turnaround time. The Idylla
TM
system as a fully automated quantitative PCR unit with a turnaround time of only 2.5 h should be proved for its reliability among Chinese CRC patients before application.
Methods:
Formalin-fixed paraffin-embedded (FFPE) tissue samples were collected from 87 CRC patients in Fudan University Shanghai Cancer Center from March 2017 to March 2019 and were subjected to detect MMR protein expression and MSI using immunochemistry (IHC)
conventional PCR (Promega MSI analysis) and the Idylla
TM
MSI system
respectively.
Results:
Of the 87 CRC patients enrolled
56 cases were identified to be deficient MMR (dMMR)/MSI-high (MSI-H) and 31 to be proficient MMR (pMMR)/microsatellite stable (MSS) by both IHC and Promega MSI analysis. However
4 cases with dMMR/MSI-H were determined to be MSS and one case with pMMR/MSS to be MSI-H using Idylla
TM
MSI system
yielding a sensitivity of 92.9% (52/56)
specificity of 96.8% (30/31) and an o
verall concordance of 94.3% (82/87). Then
the above five discordant cases were re-examined using Idylla
TM
with resection tissues
as a result
four cases with ≥20% tumor contents changed to be consistent with IHC/Promega MSI assay
however
there was still one inconsistent case with only 5% tumor content. Subsequently
the case was reconfirmed using Idylla
TM
with enriched tumor tissue by macrodissection
as expected
the result was demonstrated to be MSI-H
consistent with Promega MSI analysis and IHC. Furthermore
repeatability of the Idylla
TM
MSI assay was proved to be reliable in 5 cases with various tumor contents (20%-60%).
Conclusion:
The Idylla
TM
MSI system provides a fast
reliable and fully automated solution to MSI detection in Chinese CRC patients with high sensitivity
specificity and reproducibility
especially for CRC with more than 20% tumor contents.
VASAIKAR S , HUANG C , WANG X J , et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities [J ] . Cell , 2019 , 177 ( 4 ): 1035 - 1049 .e19. DOI: S0092-8674(19)30292-2 http://doi.org/S0092-8674(19)30292-2
BOLAND C R , GOEL A . Microsatellite instability in colorectal cancer [J ] . Gastroenterology , 2010 , 138 ( 6 ): 2073 - 2087 .e3. DOI: 10.1053/j.gastro.2009.12.064 http://doi.org/10.1053/j.gastro.2009.12.064
LYNCH H T , DE LA CHAPELLE A . Hereditary colorectal cancer [J ] . N Engl J Med , 2003 , 348 ( 10 ): 919 - 932 . DOI: 10.1056/NEJMra012242 http://doi.org/10.1056/NEJMra012242 http://www.nejm.org/doi/10.1056/NEJMra012242 http://www.nejm.org/doi/10.1056/NEJMra012242
HERMAN J G , UMAR A , POLYAK K , et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma [J ] . Proc Natl Acad Sci USA , 1998 , 95 ( 12 ): 6870 - 6875 . DOI: 10.1073/pnas.95.12.6870 http://doi.org/10.1073/pnas.95.12.6870 https://pnas.org/doi/full/10.1073/pnas.95.12.6870 https://pnas.org/doi/full/10.1073/pnas.95.12.6870
CHEN M L , CHEN J Y , HU J , et al. Comparison of microsatellite status detection methods in colorectal carcinoma [J ] . Int J Clin Exp Pathol , 2018 , 11 ( 3 ): 1431 - 1438 .
DUDLEY J C , LIN M T , LE D T , et al. Microsatellite instability as a biomarker for PD-1 blockade [J ] . Clin Cancer Res , 2016 , 22 ( 4 ): 813 - 820 . DOI: 10.1158/1078-0432.CCR-15-1678 http://doi.org/10.1158/1078-0432.CCR-15-1678
EVRARD C , TACHON G , RANDRIAN V , et al. Microsatellite instability: diagnosis, heterogeneity, discordance, and clinical impact in colorectal cancer [J ] . Cancers (Basel) , 2019 , 11 ( 10 ): E1567 .
COHEN R , HAIN E , BUHARD O , et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status [J ] . JAMA Oncol , 2019 , 5 ( 4 ): 551 - 555 . DOI: 10.1001/jamaoncol.2018.4942 http://doi.org/10.1001/jamaoncol.2018.4942
UMAR A , BOLAND C R , TERDIMAN J P , et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability [J ] . J Natl Cancer Inst , 2004 , 96 ( 4 ): 261 - 268 . DOI: 10.1093/jnci/djh034 http://doi.org/10.1093/jnci/djh034
LINDEMAN N I , CAGLE P T , BEASLEY M B , et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [J ] . J Thorac Oncol , 2013 , 8 ( 7 ): 823 - 859 . DOI: 10.1097/JTO.0b013e318290868f http://doi.org/10.1097/JTO.0b013e318290868f
SAMAISON L , GRALL M , STAROZ F , et al. Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories [J ] . J Clin Pathol , 2019 , 72 ( 12 ): 830 - 835 . DOI: 10.1136/jclinpath-2019-205935 http://doi.org/10.1136/jclinpath-2019-205935
LEE M , CHUN S M , SUNG C O , et al. Clinical utility of a fully automated microsatellite instability test with minimal hands-on time [J ] . J Pathol Transl Med , 2019 , 53 ( 6 ): 386 - 392 . DOI: 10.4132/jptm.2019.09.25 http://doi.org/10.4132/jptm.2019.09.25
LI X , XU J , LI L , et al. Evaluation of a fully automated idylla test system for microsatellite instability in colorectal cancer [J ] . Clin Colorectal Cancer , 2019 , 18 ( 4 ): e316 -e323. DOI: 10.1016/j.clcc.2019.05.006 http://doi.org/10.1016/j.clcc.2019.05.006 https://linkinghub.elsevier.com/retrieve/pii/S1533002819300866 https://linkinghub.elsevier.com/retrieve/pii/S1533002819300866
ZWAENEPOEL K , HOLMGAARD DUELUND J , DE WINNE K , et al. Clinical performance of the idylla MSI test for a rapid assessment of the DNA microsatellite status in human colorectal cancer [J ] . J Mol Diagn , 2020 , 22 ( 3 ): 386 - 395 . DOI: S1525-1578(19)30458-1 http://doi.org/S1525-1578(19)30458-1
LE D T , URAM J N , WANG H , et al. PD-1 blockade in tumors with mismatch-repair deficiency [J ] . N Engl J Med , 2015 , 372 ( 26 ): 2509 - 2520 . DOI: 10.1056/NEJMoa1500596 http://doi.org/10.1056/NEJMoa1500596 http://www.nejm.org/doi/10.1056/NEJMoa1500596 http://www.nejm.org/doi/10.1056/NEJMoa1500596
LE D T , DURHAM J N , SMITH K N , et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade [J ] . Science , 2017 , 357 ( 6349 ): 409 - 413 . DOI: 10.1126/science.aan6733 http://doi.org/10.1126/science.aan6733
AGUIAR P N Jr , TADOKORO H , FORONES N M , et al. MMR deficiency may lead to a high immunogenicity and then an improvement in anti-PD-1 efficacy for metastatic colorectal cancer [J ] . Immunotherapy , 2015 , 7 ( 11 ): 1133 - 1134 . DOI: 10.2217/imt.15.84 http://doi.org/10.2217/imt.15.84
ZHAO H , THIENPONT B , YESILYURT B T , et al. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks [J ] . Elife , 2014 , 3 : e02725 . DOI: 10.7554/eLife.02725 http://doi.org/10.7554/eLife.02725 https://elifesciences.org/articles/02725 https://elifesciences.org/articles/02725
UGUEN A , TRONCONE G . A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day [J ] . J Clin Pathol , 2018 , 71 ( 9 ): 757 - 762 . DOI: 10.1136/jclinpath-2018-205189 http://doi.org/10.1136/jclinpath-2018-205189
PÉCRIAUX A , FAVRE L , CALDERARO J , et al. Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA [J ] . J Clin Pathol , 2021 , 74 ( 1 ): 36 - 42 . DOI: 10.1136/jclinpath-2020-206581 http://doi.org/10.1136/jclinpath-2020-206581
PENG J J , HUANG D , POSTON G , et al. The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients [J ] . Oncotarget , 2017 , 8 ( 30 ): 49076 - 49083 . DOI: 10.18632/oncotarget.16176 http://doi.org/10.18632/oncotarget.16176
VELASCO A , TOKAT F , BONDE J , et al. Multi-center real-world comparison of the fully automated Idylla TM microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer [J ] . Virchows Arch , 2021 , 478 ( 5 ): 851 - 863 . DOI: 10.1007/s00428-020-02962-x http://doi.org/10.1007/s00428-020-02962-x https://doi.org/10.1007/s00428-020-02962-x https://doi.org/10.1007/s00428-020-02962-x
HAUSE R J , PRITCHARD C C , SHENDURE J , et al. Classification and characterization of microsatellite instability across 18 cancer types [J ] . Nat Med , 2016 , 22 ( 11 ): 1342 - 1350 . DOI: 10.1038/nm.4191 http://doi.org/10.1038/nm.4191
0
浏览量
2561
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621